Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP834431.RAxdSe7AxvoWuyLxjAOK9isDTNZh1uirXq1TkQq8mcG64130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP834431.RAxdSe7AxvoWuyLxjAOK9isDTNZh1uirXq1TkQq8mcG64130_assertion type Assertion NP834431.RAxdSe7AxvoWuyLxjAOK9isDTNZh1uirXq1TkQq8mcG64130_head.
- NP834431.RAxdSe7AxvoWuyLxjAOK9isDTNZh1uirXq1TkQq8mcG64130_assertion description "[However, the frequency of GSTT1 null genotype was higher among controls (28.7%) than AML cases (21.6%), which showed a protective effect of the null genotype (odds ratio?=?0.58, 95% confidence interval: 0.33-1.05, p?=?0.07).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP834431.RAxdSe7AxvoWuyLxjAOK9isDTNZh1uirXq1TkQq8mcG64130_provenance.
- NP834431.RAxdSe7AxvoWuyLxjAOK9isDTNZh1uirXq1TkQq8mcG64130_assertion evidence source_evidence_literature NP834431.RAxdSe7AxvoWuyLxjAOK9isDTNZh1uirXq1TkQq8mcG64130_provenance.
- NP834431.RAxdSe7AxvoWuyLxjAOK9isDTNZh1uirXq1TkQq8mcG64130_assertion SIO_000772 20731606 NP834431.RAxdSe7AxvoWuyLxjAOK9isDTNZh1uirXq1TkQq8mcG64130_provenance.
- NP834431.RAxdSe7AxvoWuyLxjAOK9isDTNZh1uirXq1TkQq8mcG64130_assertion wasDerivedFrom befree-2016 NP834431.RAxdSe7AxvoWuyLxjAOK9isDTNZh1uirXq1TkQq8mcG64130_provenance.
- NP834431.RAxdSe7AxvoWuyLxjAOK9isDTNZh1uirXq1TkQq8mcG64130_assertion wasGeneratedBy ECO_0000203 NP834431.RAxdSe7AxvoWuyLxjAOK9isDTNZh1uirXq1TkQq8mcG64130_provenance.